Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyclerion Therapeutics Inc
(NQ:
CYCN
)
3.040
UNCHANGED
Streaming Delayed Price
Updated: 1:06 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
117
Open
3.040
Bid (Size)
2.780 (1)
Ask (Size)
3.200 (1)
Prev. Close
3.040
Today's Range
3.040 - 3.040
52wk Range
1.750 - 6.750
Shares Outstanding
43,524,894
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
April 05, 2024
Cyclerion Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via
Benzinga
Performance
YTD
-13.14%
-13.14%
1 Month
-1.30%
-1.30%
3 Month
+0.33%
+0.33%
6 Month
+1.33%
+1.33%
1 Year
-46.59%
-46.59%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
Via
Benzinga
Cyclerion Appoints Regina Graul, Ph.D., as President
December 04, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
December 01, 2023
Via
Benzinga
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 01, 2023
Via
Benzinga
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
November 30, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 10, 2023
Via
Benzinga
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
July 31, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Via
Benzinga
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
June 01, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 16, 2023
Via
Benzinga
Cyclerion Announces Reverse Stock Split
May 15, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
May 12, 2023
Via
Benzinga
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
May 11, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
May 11, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 26, 2023
Via
Benzinga
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
April 03, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via
Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 27, 2023
Via
Benzinga
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
March 27, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
March 22, 2023
From
Cyclerion Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.